Titre:
  • Final 10-year results of the Breast International Group 2-98 phase III trial and the role of Ki67 in predicting benefit of adjuvant docetaxel in patients with oestrogen receptor positive breast cancer
Auteur:Sonnenblick, Amir; Anderson, Michael; Lluch, Ana; Gnant, Michael; Goldhirsch, Aron; Di Leo, Angelo; Barnadas, Agusti; Cortes-Funes, Hernan; Piccart-Gebhart, Martine; Crown, John; Francis, Prudence; Abdel Azim, Hatem Hamdy; Azambuja, Evandro; Nordenskjöld, B; Gutiérez, Jorge; Quinaux, Emmanuel; Mastropasqua, Mauro Giuseppe; Ameye, Lieveke
Informations sur la publication:European journal of cancer, 51, 12, page (1481-1489), 9436
Statut de publication:Publié, 2014-11
Sujet CREF:Cancérologie
Mots-clés:Adjuvant taxanes
Breast cancer
ER positive
Ki67
Pooled analysis
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0959-8049
info:doi/10.1016/j.ejca.2015.03.018
info:pii/S0959804915002853
info:scp/84936846685